Brokerages expect Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Rating) to announce sales of $3.42 million for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Agios Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $1.60 million and the highest estimate coming in at $5.93 million. The firm is scheduled […]
Analysts expect that Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Rating) will post earnings per share of ($1.78) for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Agios Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($1.71) and the lowest estimate coming in at ($1.86). Agios Pharmaceuticals reported earnings of […]
Equities analysts predict that Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Rating) will announce earnings of ($1.85) per share for the current quarter, Zacks reports. Five analysts have issued estimates for Agios Pharmaceuticals’ earnings. The highest EPS estimate is ($1.63) and the lowest is ($2.03). Agios Pharmaceuticals posted earnings of ($1.31) per share in the same […]
Brokerages expect Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Rating) to announce $1.52 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Agios Pharmaceuticals’ earnings, with the highest sales estimate coming in at $3.87 million and the lowest estimate coming in at $200,000.00. The company is […]